Viewing Study NCT05768360


Ignite Creation Date: 2025-12-25 @ 2:12 AM
Ignite Modification Date: 2025-12-27 @ 10:56 AM
Study NCT ID: NCT05768360
Status: COMPLETED
Last Update Posted: 2023-07-13
First Post: 2023-03-03
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Assess the Effects of Savolitinib on the Pharmacokinetics of Digoxin, Rosuvastatin, Metformin, and Furosemide in Healthy Male Subjects
Sponsor: AstraZeneca
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: D5084C00014
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View